Physician profile
Scott Gleason
NPI 1225454044
$43,233.60
in general payments reported to CMS, 2019-2025
10 companies · $1,686 in 2025
The $1,686 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $5,854 · 2021: $4,744 · 2022: $6,787 · 2023: $2,811 · 2024: $1,269 · 2025: $1,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,286 · Food and Beverage: $1,481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,285.56 |
| Food and Beverage | $1,480.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $31,082.31 | 2019-2025 | Arthrex |
| Wardlow Enterprises | $6,710.01 | 2020-2023 | |
| Djo, LLC | $2,916.66 | 2020 | |
| Zimmer Biomet Holdings, INC. | $1,120.97 | 2023 | Persona |
| Prism Medical | $600.53 | 2025 | |
| Vericel Corporation | $546.40 | 2023 | Maci |
| Depuy Synthes Sales INC. | $104.38 | 2021-2024 | Na |
| Axogen | $81.98 | 2019 | |
| Stryker Corporation | $61.35 | 2024-2025 | Mako, Pangea |
| Heraeus Medical, LLC. | $9.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Gleason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.